Dynamics of hemostasis system and c-reactive protein indexes while new oral anticoagulants intake in patients after hip joint endoprosthesis replacement
- Authors: Zamyatina K.N.1, Saiganov S.A.1, Mazurov V.I.1, Gaykovaya L.B.1, Tkachenko A.N.1, Urazovskaya I.L.1, Mansurov D.S.1, Khaidarov V.M.1, Balgley A.G.1
-
Affiliations:
- I.I. Mechnikov North-Western State Medical University of the Ministry of Healthcare of Russia
- Issue: Vol 7, No 10 (2021)
- Pages: 55-60
- Section: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/288684
- DOI: https://doi.org/10.18565/therapy.2021.10.55-60
- ID: 288684
Cite item
Abstract
Keywords
Full Text
![Restricted Access](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
About the authors
Ksenia N. Zamyatina
I.I. Mechnikov North-Western State Medical University of the Ministry of Healthcare of Russiapostgraduate student at the Department of biological and general chemistry named after V.V. Sokolovsky
Sergey A. Saiganov
I.I. Mechnikov North-Western State Medical University of the Ministry of Healthcare of RussiaMD, professor, rector
Vadim I. Mazurov
I.I. Mechnikov North-Western State Medical University of the Ministry of Healthcare of Russia
Email: maz.nwgmu@yandex.ru
MD, professor, academician of RAS, Chief scientific consultant, head of the Department of therapy, rheumatology, temporary disability and medical care quality examination named after E.E. Eichwald
Larisa B. Gaykovaya
I.I. Mechnikov North-Western State Medical University of the Ministry of Healthcare of RussiaMD, associate professor, head of the Department of biological and gleneral chemistry named after V.V. Sokolovsky
Alexander N. Tkachenko
I.I. Mechnikov North-Western State Medical University of the Ministry of Healthcare of RussiaMD, professor, professor of the Department of traumatology, orthopedics and mlilitary field surgery
Irina L. Urazovskaya
I.I. Mechnikov North-Western State Medical University of the Ministry of Healthcare of RussiaPhD, assistant of the Department of hospital surgery and cardiologynamed after M.S. Kushakovsky
Dzhalolidin S. Mansurov
I.I. Mechnikov North-Western State Medical University of the Ministry of Healthcare of RussiaPhD, assistant at the Department of traumatology, orthopedics and military field surgery
Valery M. Khaidarov
I.I. Mechnikov North-Western State Medical University of the Ministry of Healthcare of RussiaPhD, associate professor of the Department of traumatology, orthopedics and military field surgery
Alexander G. Balgley
I.I. Mechnikov North-Western State Medical University of the Ministry of Healthcare of Russiaassistant at the Department of traumatology, orthopedics and military field surgery
References
- Ortel T.L., Neumann I., Ageno W. et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: Treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020; 4(19): 4693-738. doi: 10.1182/ bloodadvances.2020001830.
- Samama M.M., Martinoli J-L., LeFlem L. et al. Assessment of laboratory assays to measure rivaroxaban - an oral, direct factor Xa inhibitor. Thromb Haemost. 2010; 103(4): 815-25. doi: 10.1160/TH09-03-0176.
- Christersson C., Oldgren J., Wallentin L., Siegbahn A. Treatment with an oral direct thrombin inhibitor decreases platelet activity but increases markers of inflammation in patients with myocardial infarction. J. Intern Med. 2011; 270(3): 215-23. doi: 10.1111/j.1365-2796.2011.02354.x.
- Tamigniau A., Douxfils J., Nicolas J-B. et al. [Why, when and how to monitor new oral anticoagulants]. Rev Med Suisse. 2014; 10(416): 326-33.
- Ревишвили А.Ш., Шляхто Е.В., Замятин М.Н. с соавт. Особенности оказания экстренной и неотложной медицинской помощи пациентам, получающим прямые оральные антикоагулянты. Согласительный документ междисциплинарной группы экспертов. Вестник аритмологии. 2018; 92: 59-72. [Revishvili A.Sh., Shlyakhto E.V., Zamyatin M.N. et al. Features of the provision of emergency and urgent medical care to patients receiving direct oral anticoagulants. Consensus document of the interdisciplinary expert group. Vestnik aritmologii = Herald of Arrhythmology. 2018; 92: 59-72 (In Russ.)]. https://dx.doi.org/10.25760/VA-2018-92-59-72.
- Lindhoff-Last E., Samama M.M., Ortel T.L. et al. Assays for measuring rivaroxaban: their suitability and limitations. Ther Drug Monit. 2010; 32(6): 673-79. doi: 10.1097/FTD.0b01381f2f264.
- Douxfils J., Ageno W., Samama C-M. et al. Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians. J. Thromb Haemost. 2018; 16(2): 209-19. doi: 10.1111/jth.13912.
- Сычев Д.А., Синицына И.И., Цомая И.В. с соавт. Клинико-фармакологическое и клиническое обоснование кратности применения новых пероральных антикоагулягтов. Кардиология. 2017; 11: 84-93. [Sychev D.A., Sinitsyna I.I., Tsomaya I.V. et al. Clinical, pharmacological and clinical substantiation of the frequency of use of new oral anticoagulants. Kardiologiya = Cardiology. 2017; 11: 84-93 (In Russ.)]. https://dx.doi.org/10087/cadio.2017/11/10058.
- Cuker A., Siegal D.M., Crowther M.A., Garcia D.A. Laboratory measurement of the anticoagulant activity of the non-vitamin K. oral anticoagulants. J. Am Coll Cardiol. 2014; 64(11): 1128-39. doi: 10.1016/j.jacc.2014.05.065.
- Spyropoulos A.C., Al-Badri A., Sherwood M.W., Douketis J.D. To measure or not to measure direct oral anticoagulants before surgery or invasive procedures: Comment. J. Thromb Haemost. 2016; 14(12): 2556-59. doi: 10.1111/jth.13505.
- Highcock A.J., As-Sultany M., Finley R., Donnachie N.J. A Prospective cohort comparative study of rivaroxaban, dabigatran, and apixaban oral thromboprophylaxis in 2431 hip and knee arthroplasty patients: Primary efficacy out-comes and safety profile. J. Arthroplasty. 2020; 35(11): 3093-98. doi: 10.1016/j.arth.2020.06.032.
- Connors J.M. Testing and monitoring direct oral anticoagulants. Blood. 2018; 132(19): 2009-15. doi: 10.1182/blood-2018-04-791541.
- Battistelli S., Fortina M., Carta S. et al. Serum C-reactive protein and procalcitonin kinetics in patients undergoing elective total hip arthroplasty. Biomed Res Int. 2014; 2014: 565080. doi: 10.1155/2014/565080.
- Jiang Y., Li J., Liu Y. et al. Risk factors for deep vein thrombosis after orthopedic surgery and the diagnostic value of D-dimer. Ann Vasc Surg. 2015; 29(4): 675-81. doi: 10.1016/j.avsg.2014.12.022.
- Paruk F., Chausse J.M. Monitoring the post surgery inflammatory host response. J. Emerg Crit Care Med. 2019; 3: 47. doi: 10.21037/ jeccm.2019.08.06.
- Poredos P., Poredos P., Jezovnik M.K. et al. Time course of inflammatory and procoagulant markers in the early period after total hip replacement. Clin Appl Thromb Hemost. 2021; 27: 1076029620985941. doi: 10.1177/1076029620985941.
Supplementary files
![](/img/style/loading.gif)